ASH logo

Ashland Inc. Stock Price

NYSE:ASH Community·US$2.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

ASH Share Price Performance

US$48.94
-38.84 (-44.25%)
38.1% undervalued intrinsic discount
US$79.00
Fair Value
US$48.94
-38.84 (-44.25%)
38.1% undervalued intrinsic discount
US$79.00
Fair Value
Price US$48.94
AnalystHighTarget US$79.00
AnalystConsensusTarget US$65.65
AnalystLowTarget US$53.00

ASH Community Narratives

AnalystHighTarget·
Fair Value US$79 38.1% undervalued intrinsic discount

Environmental And Urban Trends Will Widen Specialty Chemical Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$64.7 24.4% undervalued intrinsic discount

Sustainable Bio-based Chemicals Will Capture Asia And Latin America

1users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystLowTarget·
Fair Value US$53 7.7% undervalued intrinsic discount

China Overcapacity And Tightening Environmental Rules Will Squeeze Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$64.7
24.4% undervalued intrinsic discount
Revenue growth
1.92% p.a.
Profit Margin
17.54%
Future PE
9.77x
Share price in 2028
US$81.23
US$53
7.7% undervalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
1.45% p.a.
Profit Margin
15.11%
Future PE
8.49x
Share price in 2028
US$66.77

Snowflake Analysis

Fair value with moderate growth potential.

1 Risk
3 Rewards

Ashland Inc. Key Details

US$1.9b

Revenue

US$1.2b

Cost of Revenue

US$622.0m

Gross Profit

US$1.5b

Other Expenses

-US$836.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-18.29
33.28%
-44.73%
73.2%
View Full Analysis

About ASH

Founded
1924
Employees
2960
CEO
Guillermo Novo
WebsiteView website
www.ashland.com

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.

Recent ASH News & Updates

Recent updates

No updates